Alpha Tau Medical (NASDAQ:DRTS – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Monday, Zacks.com reports. According to Zacks, “Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha […]
Zacks Investment Research upgraded shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) from a sell rating to a hold rating in a report published on Thursday, Zacks.com reports. According to Zacks, “Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha DaRT for the […]
Penumbra (NYSE:PEN – Get Rating) and Alpha Tau Medical (NASDAQ:DRTS – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, analyst recommendations, risk and institutional ownership. Insider and Institutional Ownership 79.4% of Penumbra shares are held […]
Piper Sandler began coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) in a research note issued to investors on Friday morning, MarketBeat Ratings reports. The firm issued an overweight rating and a $19.00 price objective on the stock. Several other brokerages have also recently issued reports on DRTS. Citigroup started coverage on […]
Zacks Investment Research cut shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) from a hold rating to a sell rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha […]